Literature DB >> 28360578

Comorbidity of Migraine.

Şebnem Biçakci1.   

Abstract

Migraine is a common neurological disorder and can be severely disabling during attacks. The highest prevalence occurs between the ages of 25 and 55 years. Prior studies have found that migraine occurs together with other illnesses at a greater coincidental rate than is seen in the general population. These occurrences are called "comorbidities". To delineate the comorbidities of migraine is important, because it can help improve treatment strategies and the understanding of the possible pathophysiology of migraine.

Entities:  

Keywords:  Migraine; comorbidity

Year:  2013        PMID: 28360578      PMCID: PMC5353072          DOI: 10.4274/Npa.y7281

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  87 in total

1.  Migraine and Tourette syndrome.

Authors:  Piero Barbanti; Giovanni Fabbrini
Journal:  Arch Neurol       Date:  2004-04

2.  Childhood periodic syndromes: a population-based study.

Authors:  Marco A Arruda; Vincenzo Guidetti; Federica Galli; Regina C A P Albuquerque; Marcelo E Bigal
Journal:  Pediatr Neurol       Date:  2010-12       Impact factor: 3.372

Review 3.  Comorbidity of migraine.

Authors:  Ann I Scher; Marcelo E Bigal; Richard B Lipton
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

4.  Headache types and panic disorder: directionality and specificity.

Authors:  N Breslau; L R Schultz; W F Stewart; R Lipton; K M Welch
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

5.  Association between restless legs syndrome and migraine.

Authors:  Ping-Kun Chen; Jong-Ling Fuh; Shih-Pin Chen; Shuu-Jiun Wang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-11-30       Impact factor: 10.154

6.  Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study.

Authors:  Mário Wiehe; Sandra Costa Fuchs; Leila B Moreira; Renan Stoll Moraes; Flávio D Fuchs
Journal:  J Hypertens       Date:  2002-07       Impact factor: 4.844

7.  ACE D/I polymorphism, migraine, and cardiovascular disease in women.

Authors:  M Schürks; R Y L Zee; J E Buring; T Kurth
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

8.  Migraine, suicidal ideation, and suicide attempts.

Authors:  N Breslau
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

9.  Stroke and migraine in the Oxfordshire Community Stroke Project.

Authors:  J B Henrich; P A Sandercock; C P Warlow; L N Jones
Journal:  J Neurol       Date:  1986-10       Impact factor: 4.849

10.  "Comorbidity" between epilepsy and headache/migraine: the other side of the same coin!

Authors:  Pasquale Striano; Vincenzo Belcastro; Alberto Verrotti; Pasquale Parisi
Journal:  J Headache Pain       Date:  2011-07-31       Impact factor: 7.277

View more
  4 in total

1.  An open/pilot trial of cognitive behavioral therapy in Turkish patients with refractory chronic migraine.

Authors:  Ozge Sahmelikoglu Onur; Devrimsel Harika Ertem; Cagatay Karsidag; Derya Uluduz; Aynur Ozge; Aksel Sıva; Meltem Guru
Journal:  Cogn Neurodyn       Date:  2019-01-12       Impact factor: 5.082

2.  Quality of life in children and adolescents with migraine: an Austrian monocentric, cross-sectional questionnaire study.

Authors:  Lydia Stella Koller; Susanne C Diesner; Peter Voitl
Journal:  BMC Pediatr       Date:  2019-05-24       Impact factor: 2.125

3.  Studies on the Mechanism of Glutamate Metabolism in NTG-Induced Migraine Rats Treated with DCXF.

Authors:  Ni Ni; Qingqing Wang; Xiao Lin; Yanlong Hong; Yi Feng; Lan Shen
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-31       Impact factor: 2.629

4.  The migraine signature study: Methods and baseline results.

Authors:  Alice R Pressman; Dawn C Buse; Alice S Jacobson; Shruti J Vaidya; Alexandra B Scott; Victoria M Chia; Christine A Szekely; Walter F Stewart; Richard B Lipton
Journal:  Headache       Date:  2020-12-23       Impact factor: 5.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.